CSE-1034
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CSE-1034, covering 2019-08-29 to 2019-08-29. Get the full timeline:
Most recent: Clinical Trial Update: CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria [Phase 3]